Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers of the University of ...

Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers have identified a deficit in contrast perception in people with schizophrenia. According to a ...

Scientists at Stanford Medicine are advancing the understanding of schizophrenia by creating a "periodic table" for ...

Boehringer Ingelheim announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia ...

The company has said that all three of its CONNEX trials failed to meet expectations showing no significant impact on the ...

In this last context, it is notable that, before panic disorder was described as a separate entity, patients with this disorder were frequently diagnosed as having schizophrenia. [37] In a more ...

Researchers from Singapore's National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, Technology and Research (A*STAR) have made strides in understanding the ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints were ...

Boehringer believes that the results will aid scientific understanding and inform future research for patients living with cognitive impairment in schizophrenia, an area of high unmet need with no ...

Our gratitude goes to the patients and clinical investigators whose time and commitment made this research possible.” CONNEX was the largest program for cognitive impairment in schizophrenia to ...

Our gratitude goes to the patients and clinical investigators whose time and commitment made this research possible.” CONNEX was the largest program for cognitive impairment in schizophrenia to date.